Results 21 to 30 of about 33,501 (182)

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers [PDF]

, 2012
BACKGROUND Atrial fibrillation is a serious public health problem posing a considerable burden to not only patients, but the healthcare environment due to high rates of morbidity, mortality, and medical resource utilization. There are limited data on the
AJ Camm, Aldo P Maggioni, Alexandra A Bernhardt, Alfonso Martín, Anselm K Gitt, AS Go, B Lown, BN Singh, CA Sanoski, CX Wong, François Chazelle, Gregory YH Lip, GV Naccarelli, H Stefansdottir, Harry JGM Crijns, Hemant M Phatak, IC Van Gelder, IC Van Gelder, J Heeringa, Jean-Yves Le Heuzey, JML Hendriks, K Wachtell, Lori D Bash, Mauricio Scanavacca, MM Gallagher, Mårten Rosenqvist, P Alboni, Piotr Ponikowski, Prashanthan Sanders, R Pisters, RG Tieleman, S DeWilde, Sreevalsa Unniachan, T Meinertz, Thorsten Lewalter, VE Hagens, Y Miyasaka   +36 more
core   +3 more sources

Short and Intermediate Term Outcomes of the Convergent Procedure: Initial Experience in a Tertiary Referral Center [PDF]

, 2020
PURPOSE: The Convergent procedure is a hybrid, multidisciplinary treatment for symptomatic atrial fibrillation (AF) consisting of minimally invasive surgical epicardial ablation and percutaneous/catheter endocardial ablation.
Hirsh, Jeffrey, Lantz, Gurion, Lee, Lawrence S., Mahlow, Jeremy, Tonks, Robert   +4 more
core   +1 more source

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Anticoagulation is indicated for 4 weeks after cardioversion in patients with atrial fibrillation/flutter. We sought to examine whether there is evidence of sex or racial disparity in anticoagulant prescription following cardioversion, and ...
Amgad Mentias, Shady Nakhla, Milind Y. Desai, Oussama Wazni, Venu Menon, Samir Kapadia, Mary Vaughan Sarrazin   +6 more
doaj   +1 more source

Atrial Fibrillation in Eight New World Camelids. [PDF]

, 2015
BackgroundThere is limited information on the incidence of clinical signs, concurrent illness and treatment options for atrial fibrillation (AF) in New World Camelids (NWC).ObjectiveDescribe clinical signs and outcome of AF in NWC.AnimalsEight New World ...
Bozorgmanesh, R, Estell, KE, Griffiths, LG, Magdesian, KG, Stern, JA, Swain, EA   +5 more
core   +1 more source

The incidence of left atrial appendage thrombi on transesophageal echocardiography after pretreatment with apixaban for cardioversion in the real-world practice.

PLoS ONE, 2018
The risk of thromboembolisms during the post-cardioversion period is high. For patients with persistent atrial fibrillation (AF), anticoagulation with warfarin (INR 2.0~3.0) is recommended for at least three weeks prior and four weeks after cardioversion.
Jongmin Hwang, Hyoung-Seob Park, Seung-Woon Jun, Sang-Woong Choi, Cheol Hyun Lee, In-Cheol Kim, Yun-Kyeong Cho, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Seung-Ho Hur, Sang Hoon Lee, Seongwook Han   +12 more
doaj   +1 more source

Impact of electric cardioversion on platelet activation.

PLoS ONE, 2021
IntroductionAtrial fibrillation (AF) comes along with high risk of stroke. This risk continues even after re-establishing sinus rhythm with cardioversion.
Harald Haidl, Johanna Gaugler, Gerhard Cvirn, Hildegard Jasser-Nitsche, Wolfgang Schwinger, Sina Pohl, Egbert Bisping, Siegfried Gallistl, Axel Schlagenhauf   +8 more
doaj   +1 more source

Impact of atrial fibrillation on the cardiovascular system through a lumped-parameter approach [PDF]

, 2014
Atrial fibrillation (AF) is the most common arrhythmia affecting millions of people in the Western countries and, due to the widespread impact on the population and its medical relevance, is largely investigated in both clinical and bioengineering ...
Camporeale, Carlo, Guala, Andrea, Ridolfi, Luca, Scarsoglio, Stefania   +3 more
core   +2 more sources

Initial Energy for External Electrical Cardioversion of Atrial Fibrillation

Arquivos Brasileiros de Cardiologia, 2002
OBJECTIVE - To investigate the initial energy level required for electrical cardioversion of atrial fibrillation (AF). METHODS - We studied patients undergoing electrical cardioversion in the 1st Multicenter Trial of SOCESP.
Edilberto Figueiredo, Henrique Horta Veloso, Angelo Amato Vincenzo de Paola   +2 more
doaj   +1 more source

Analysis of haematological and biochemical blood parameters after electrical cardioversion of atrial fibrillation in dogs

Journal of Veterinary Research, 2018
Electrical cardioversion is a therapeutic procedure used to convert various types of arrhythmias back to sinus rhythm. It is used to restore the sinus rhythm in dogs with atrial fibrillation.
Noszczyk-Nowak Agnieszka, Michałek Marcin, Janiszewski Adrian, Kurosad Agnieszka, Sławuta Agnieszka, Cepiel Alicja, Pasławska Urszula   +6 more
doaj   +1 more source

The Risk of Thromboembolic Complications in Fontan Patients with Atrial Flutter/fibrillation Treated with Electrical Cardioversion [PDF]

, 2016
Atrial flutter or fibrillation (AFF) remains a major chronic complication of the Fontan procedure. This complication further predisposes this patient population to thromboembolic events.
Cordes, Timothy M., Kean, Adam C., Lin, Jiuann-Huey I.   +2 more
core   +1 more source